Riskpilot← Back to searchSign inGet full accessLivio Gärdet AB
ABDissolvedOrg 5566218318Medical specialists activities · NACE 8622Est. 20020 employees
Revenue 2024
SEK 41,6M
-4% vs 2023
EBITDA margin
12.2%
+9% vs 2023
Equity ratio
1.6%
Financial strength
Net profit 2024
SEK -34K
+94% vs 2023
| Revenue | SEK 41,6M | -4% |
| EBITDA | SEK 5,1M | +9% |
| Net profit | SEK -34K | +94% |
| Total assets | SEK 14,9M | -12% |
| Equity | SEK 242K | -12% |
| Employees | 0 | — |
Legal name
Livio Gärdet AB
Org number
5566218318
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
10 januari 2002
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva hälso- och sjukvårdsverksamhet, forskning, utbildning och konsultverksamhet i anslutning därtill. Ävensom idka därmed förenlig verksamhet.
Address
Email
infosth@fcivf.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 36 872 | 40 763 | 38 407 | 43 368 | 41 609 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 6 211 | 8 735 | 4 131 | 4 660 | 5 078 |
| Depreciation & amort. | −744 | −514 | −342 | −371 | −457 |
| EBIT | 5 467 | 8 221 | 3 789 | 4 289 | 4 621 |
| Net financials | −1 | — | 7 | 36 | 4 |
| Profit before tax | 50 | 55 | −453 | −565 | −34 |
| Tax | −17 | −16 | −0 | −0 | −0 |
| Net profit | 33 | 39 | −453 | −565 | −34 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 411 | 15 784 | 12 360 | 16 868 | 14 885 |
| Equity | 656 | 694 | 241 | 276 | 242 |
| Long-term debt | 0 | 0 | 0 | 0 | 3 413 |
| Short-term debt | 7 963 | 14 381 | 11 526 | 16 013 | 11 230 |
| Total debt | 7 963 | 14 381 | 11 526 | 16 013 | 14 643 |
EBITDA margin
12.2%
This company
15.8%
Market median
-23% vs market
20202024
Equity ratio
1.6%
This company
38.2%
Market median
-96% vs market
20202024
Return on equity
-14.0%
This company
18.4%
Market median
-176% vs market
20202024
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20202024
Asset turnover
2.80×
This company
1.12×
Market median
+150% vs market
20202024
Debt / equity
60.51×
This company
0.62×
Market median
-9660% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PF Chief Auditor | Chief Auditor | 2024 |
| Former (1) | ||
MI Chief Auditor | Chief Auditor | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (4) | ||
| Board of Directors | 2022 – 2024 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2024 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KKR GENESIS BIDCO S.L.U
Livio Gärdet AB Board members of Livio Gärdet AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Petter Fredrik Engdahl | Chief Auditor | 0 companies |
| Magnus Ivar Thorling | Chief Auditor | 0 companies |
| Anna Karin Helena Lind | Deputy Board Member | 0 companies |
| Karl Henrik Hernander | Board of Directors | 0 companies |
| Eva Anna-Carin Strandberg | Board of Directors | 0 companies |
| Björn Åke Steffan Lundberg | Deputy Board Member | 0 companies |
| Anna Karolina Anbratt | Deputy Board Member | 0 companies |
| Eugene Maxwell Marsden | Board of Directors | 0 companies |